Figure S4 from Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases | Synapse
April 3, 2024Open Access
Figure S4 from Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases
Key Points
Key points are not available for this paper at this time.
Abstract
Supplemental Figure 4. CA-4948 viability assessment in A20 and B16F10 cancer cells.